Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 27, 2026 05:00 ET | Source: StarkAge Therapeutics

StarkAge Therapeutics Announces Research Collaboration with Gustave Roussy to Advance Senolytic Therapies in Digestive Cancers

The collaboration will inform patient selection for treatment with STX-1, a first-in-class senolytic ADC directed against DPP4/CD26.